Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)

Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2021
Cargando información sobre las referencias
This is a double-blind, randomized, vehicle controlled Phase 3 study to evaluate the efficacy and safety of topical tapinarof cream, 1% compared to vehicle control cream in pediatric and adult subjects with atopic dermatitis.
Epistemonikos ID: a6fbed072d9b66384916d5eae7822db9c9884cda
First added on: May 09, 2024